{"precision": 0.4444444444444444, "recall": 0.5714285714285714, "macro_F1": 0.5, "micro_F1": 0.5555555555555555, "accuracy": 0.3333333333333333, "correct_cases": {"4201": {"text": "Syncope in a 65-year - old woman after nitrate ingestion .", "true": [["syncope", "nitrate"]], "pred": [["syncope", "nitrate"]], "response": " [['Syncope', 'nitrate']]\nExplanation: The 65-year-old woman experienced syncope after ingesting nitrate."}, "30": {"text": "Pravastatin is associated with myotonia in animals .", "true": [["myotonia", "pravastatin"]], "pred": [["myotonia", "pravastatin"]], "response": " [['myotonia', 'pravastatin']]\nExplanation: Pravastatin caused myotonia in animals."}}, "fail_cases": {"2290": {"text": "We present the case of an adult Crohn 's disease patient with a parvovirus B19 infection and leukopenia during long - term AZA therapy .", "true": [["leukopenia", "aza"]], "pred": [["parvovirus b19 infection", "aza"], ["leukopenia", "aza"]], "response": " [['parvovirus B19 infection', 'AZA'], ['leukopenia', 'AZA']]\nExplanation: The patient developed parvovirus B19 infection and leukopenia while on long-term AZA therapy for Crohn's disease."}, "1098": {"text": "Our patient was a 72-year - old man with advanced Parkinson 's disease ( PD ) who received levodopa and anti - cholinergic drugs and whose head had become almost completely bald .", "true": [["completely bald", "levodopa"]], "pred": [["baldness", "levodopa"], ["baldness", "anti - cholinergic drugs"]], "response": " [['baldness', 'levodopa'], ['baldness', 'anti - cholinergic drugs']]\nExplanation: The patient's baldness was caused by both levodopa and anti-cholinergic drugs."}, "2233": {"text": "Although his renal function recovered completely with high - dose leucovorin , hemodialysis , charcoal hemoperfusion , and carboxypeptidase G2 , we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4-hour MTX infusion , and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4-hour MTX infusion .", "true": [["renal toxicity", "mtx"]], "pred": [["renal toxicity", "mtx"], ["signs of renal toxicity", "mtx"]], "response": " [['renal toxicity', 'MTX'], ['signs of renal toxicity', 'MTX']]\nExplanation: MTX can cause renal toxicity, which can be seen as early as 2 hours after completion of a 4-hour infusion and should be monitored for within a few hours after completion of the infusion."}, "1237": {"text": "Thalidomide neuropathy is often associated with proximal weakness and may progress even after discontinuation of treatment , in the phenomenon of ' coasting ' .", "true": [["neuropathy", "thalidomide"], ["proximal weakness", "thalidomide"]], "pred": [["thalidomide neuropathy", "thalidomide"]], "response": " [['Thalidomide neuropathy', 'thalidomide']]\nExplanation: Thalidomide neuropathy can cause proximal weakness and may continue to progress after treatment is discontinued."}}, "missing_cases": {"1098": [["completely bald", "levodopa"]], "1237": [["neuropathy", "thalidomide"], ["proximal weakness", "thalidomide"]]}, "false_cases": {"2290": [["parvovirus b19 infection", "aza"]], "1098": [["baldness", "anti - cholinergic drugs"], ["baldness", "levodopa"]], "2233": [["signs of renal toxicity", "mtx"]], "1237": [["thalidomide neuropathy", "thalidomide"]]}}